IP Library Assignment 059400/0489
Patent Assignment
Reel/Frame 059400/0489

Assignment of Assignor's Interest

Recorded: 2022-03-25 Pages: 10
Assignors
MANNING, PAMELA T.
Executed: 2022-03-21
PURO, ROBYN
Executed: 2022-03-21
ALMAGRO, JUAN C.
Executed: 2022-03-16
KARR, ROBERT W.
Executed: 2022-03-16
Assignee
ARCH ONCOLOGY, INC.
2000 SIERRA POINT PKWY, SUITE 700, BRISBANE, CALIFORNIA, 94005
Covered Properties (4)
Therapeutic CD47 Antibodies
Application: 15/871,802 →
Publication: US 2018/0142019
Therapeutic CD47 Antibodies
Application: 16/223,009 →
Publication: US 2019/0112373
Therapeutic CD47 Antibodies
Application: 16/703,484 →
Publication: US 2020/0095318
Therapeutic CD47 Antibodies
Application: 16/942,531 →
Publication: US 2021/0079091
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 21, 2018
From: MANNING, PAMELA T.; PURO, ROBYN; ALMAGRO, JUAN C.; KARR, ROBERT W.
To: TIOMA THERAPEUTICS, INC.
Reel/Frame 044993/0229 →
Change of Name Mar 21, 2018
From: TIOMA THERAPEUTICS, INC.
To: ARCH ONCOLOGY, INC.
Reel/Frame 045677/0431 →
Change of Name Apr 24, 2018
From: TIOMA THERAPEUTICS, INC.
To: ARCH ONCOLOGY, INC.
Reel/Frame 046006/0204 →
Assignment of Assignor's Interest Aug 2, 2019
From: MANNING, PAMELA T.; PURO, ROBYN; ALMAGRO, JUAN C.; KARR, ROBERT W.
To: TIOMA THERAPEUTICS, INC.
Reel/Frame 049943/0892 →
Change of Name Aug 2, 2019
From: TIOMA THERAPEUTICS, INC.
To: ARCH ONCOLOGY, INC.
Reel/Frame 049950/0454 →
Assignment of Assignor's Interest Dec 16, 2024
From: ARCH ONCOLOGY, INC.
To: CAPRICE THERAPEUTICS, LLC
Reel/Frame 069600/0672 →